| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
NEWTOWN, Pa.—BioClinica Inc., a global provider ofclinical trial management services, recently announced the BioClinicaIntegrated Operations Platform (BIOP) as part of its showcasing of its BioClinicaeClinical Technology Suite at the 46th Drug Information Association AnnualMeeting this week in Washington, D.C.
 
 
The BIOP is being touted as an advancement inclinical support technology because it "leverages the power, the familiarity,and the ubiquity of Microsoft Office and SharePoint platforms to deliver a realworld window on clinical operations—across studies and across clinicaltechnologies." 
 
BioClinica notes that it will makemission-critical operational data accessible in Microsoft Office and SharePointapplications that it anticipates most of its customers already use and are veryfamiliar in using.
 
 
"Our customers told us that they needed a simplerway to centralize and share their operational data for managing clinical trials,"says Mark Weinstein, CEO of BioClinica. "Through our work with Microsoft we areembracing the SharePoint and Office tools that many customers already have anduse. Unlike other solutions, this platform un-tethers the clinical data, makingthe data more easily accessible and therefore more usable."
 
 
SharePoint is said to be one of the fastest-growingserver products in Microsoft history, with more than 100 million licenses sold.
 
 
"To keep up with market demands, life sciencescompanies are under increased pressure to speed the pace of clinical trials andquickly bring new drugs to market," says Michael Naimoli, director of lifesciences industry solutions at Microsoft Corp. "With the integration of our Officeand SharePoint platforms, BioClinica customers can liberate their data for acomprehensive, real-time view into studies and pertinent information, withOffice Smart clinical trial management systems."

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A blue x-ray style image of a human body is shown with the liver illuminated in orange against a dark blue background.

Harnessing liver-on-a-chip models for drug safety

Discover how researchers leverage microphysiological systems in toxicology studies.  
A person wearing a white lab coat types on a laptop with various overlaid enlarged files shown with plus signs on file folders floating over the laptop screen with a clinical lab shown in the background in grey and white tones.

Enhancing bioanalytical studies with centralized data management

Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.

Explained: How are metabolite biomarkers improving drug discovery and development?

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue